Your right , Syhygmocar meets all recommended requirements but the competition will concentrate on a cheaper product to measure central aortic blood pressure . We need to see which one the clinics take up.
"central aortic blood pressure wave separation analysis is recommended when testing is focused on the role of wave reflection as either an exposure for a cardiovascular outcome or a target for intervention. Regarding the size of treatment effect, both measurements were highly rated and within the top two categories assigned by the AHA. Central aortic wave separation analysis received a Class 1 designation and carotid-femoral pulse wave velocity a Class lla designation."
Ann: App 4E / Full Year Statutory Accounts, page-11
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.35M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14197 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 9803 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable